|
|
| | 4-(1,8-diazabicyclo[4.3.0]nona-6,8-dien-2-yl)benzonitrile hydrochloride Basic information |
| | 4-(1,8-diazabicyclo[4.3.0]nona-6,8-dien-2-yl)benzonitrile hydrochloride Chemical Properties |
| | 4-(1,8-diazabicyclo[4.3.0]nona-6,8-dien-2-yl)benzonitrile hydrochloride Usage And Synthesis |
| Originator | Arensin,Ciba-Geigy | | Uses | Antineoplastic. | | Definition | ChEBI: Fadrozole hydrochloride is an imidazopyridine. | | Manufacturing Process | 5-p-Cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine hydrochloride:
A solution of 2.0 g of 4-(4-chloro-4-p-cyanophenyl-n-butyl)-1H-imidazole in
50 ml of chloroform is refluxed for 4 hours under nitrogen, cooled and
evaporated to yield the 5-p-cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine hydrochloride; melting point 231-233°C (from 2-propanol).
Preparation of the starting materials:
A solution of 1.82 g of 4-(3-ethoxycarbonylpropyl)-1H-imidazole in 30 ml of
tetrahydrofuran under nitrogen is treated with 0.5 g of sodium hydride (50%
oil dispersion) at 0°C for 30 min and 1.45 ml of trimethylsilyl chloride at 0°C
for 3 hours. The reaction mixture is washed with cold 0.5 N sodium
bicarbonate solution, dried over sodium sulfate and evaporated to dryness.
The oil is redissolved in 100 ml of methylene chloride at -78°C under nitrogen
and 12.82 ml of diisobutylaluminum hydride (1.56 M) is added dropwise. The
reaction mixture is stirred for 5 min at -78°C, quenched with 1 ml of
methanol followed by 10 ml of water and filtered through Celite?. The organic
phase is separated, dried over sodium sulfate and evaporated to yield the title
compound (a).
(b) 4-(4-p-t-Butylaminocarbonylphenyl-4-hydroxy-n-butyl)-1-trimethylsilylim
idazole:6.95 g of p-tert-butylaminocarbonylbromobenzene is dissolved in 175 ml of
tetrahydrofuran at -70°C under nitrogen and 20.1 ml of a solution of n-butyl
lithium (2.7 m) in hexane is added dropwise. After reacting 30 min, a solution
of 5.69 g of 4-(3-formyl-n-propyl)-1-trimethylsilyl imidazole in 10 ml of
tetrahydrofuran is added slowly. The reaction mixture is allowed to warm
slowly to room temperature and 20 ml of ammonium chloride is added. The
organic layer is separated, dried over sodium sulfate and evaporated to yield
the title compound (b).
(c) 4-(4-Chloro-4-p-cyanophenyl-n-butyl)-1H-imidazole:
A solution of 4.5 g of 4-(4-p-t-butylaminocarbonylphenyl-4-hydroxy-n-butyl)-
1-trimethylsilylimidazole in 50 ml of thionyl chloride is refluxed for 1 hour,
cooled and evaporated. The residue is partitioned between methylene chloride
and aqueous sodium bicarbonate solution. The organic phase is separated,
dried over sodium sulfate and evaporated to yield the title compound (c).
5-p-Cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine:
A solution of 2.0 g of 4-(4-chloro-4-p-cyanophenyl-n-butyl)-1H-imidazole in
50 ml of chloroform is refluxed for 4 hours under nitrogen, cooled and
evaporated to yield the 5-p-cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-
a]pyridine. | | Therapeutic Function | Antineoplastic |
| | 4-(1,8-diazabicyclo[4.3.0]nona-6,8-dien-2-yl)benzonitrile hydrochloride Preparation Products And Raw materials |
|